These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 3977957)

  • 1. Auramine O as a fluorescent probe for the binding of basic drugs to human alpha 1-acid glycoprotein (alpha 1-AG). The development of a simple fluorometric method for the determination of alpha 1-AG in human serum.
    Sugiyama Y; Suzuki Y; Sawada Y; Kawasaki S; Beppu T; Iga T; Hanano M
    Biochem Pharmacol; 1985 Mar; 34(6):821-9. PubMed ID: 3977957
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of binedaline binding to human alpha 1-acid glycoprotein and other serum proteins by chlorpromazine, imipramine, and propranolol.
    Morin D; Zini R; Ledewyn S; Tillement JP
    J Pharm Sci; 1986 Sep; 75(9):883-5. PubMed ID: 3783457
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The use of auramine O to study ligand binding and subunit cooperativity of lactate dehydrogenase.
    Ivanov MV; Kube D; Nagradova NK
    Biochim Biophys Acta; 1984 Sep; 789(2):216-23. PubMed ID: 6477930
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assessment of the contribution of alpha 1-acid glycoprotein to the serum binding of basic drugs using serum treated with sulphosalicylic acid and DEAE-cellulose.
    Suzuki Y; Sugiyama Y; Sawada Y; Iga T; Hanano M
    J Pharm Pharmacol; 1985 Oct; 37(10):712-7. PubMed ID: 2867139
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A simple and rapid fluorometric determination method of alpha 1-acid glycoprotein in serum using quinaldine red.
    Imamura H; Maruyama T; Okabe H; Shimada H; Otagiri M
    Pharm Res; 1994 Apr; 11(4):566-70. PubMed ID: 8058617
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Binding of psychotropic drugs to isolated alpha-acid glycoprotein.
    Kornguth ML; Hutchins LG; Eichelman BS
    Biochem Pharmacol; 1981 Sep; 30(17):2435-41. PubMed ID: 21043242
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of a common binding site for basic drugs on human alpha 1-acid glycoprotein (orosomucoid).
    Müller WE; Stillbauer AE
    Naunyn Schmiedebergs Arch Pharmacol; 1983 Mar; 322(2):170-3. PubMed ID: 6866130
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Binding of disopyramide, methadone, dipyridamole, chlorpromazine, lignocaine and progesterone to the two main genetic variants of human alpha 1-acid glycoprotein: evidence for drug-binding differences between the variants and for the presence of two separate drug-binding sites on alpha 1-acid glycoprotein.
    Hervé F; Duché JC; d'Athis P; Marché C; Barré J; Tillement JP
    Pharmacogenetics; 1996 Oct; 6(5):403-15. PubMed ID: 8946472
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A comparative study of the interaction of warfarin with human alpha 1-acid glycoprotein and human albumin.
    Otagiri M; Maruyama T; Imai T; Suenaga A; Imamura Y
    J Pharm Pharmacol; 1987 Jun; 39(6):416-20. PubMed ID: 2886597
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of quinaldine red as a fluorescent probe for studies of drug-alpha 1-acid glycoprotein interaction.
    Imamura H; Maruyama T; Otagiri M
    Biol Pharm Bull; 1993 Sep; 16(9):926-9. PubMed ID: 8268861
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Displacement of lidocaine from serum alpha 1-acid glycoprotein binding sites by basic drugs.
    Goolkasian DL; Slaughter RL; Edwards DJ; Lalka D
    Eur J Clin Pharmacol; 1983; 25(3):413-7. PubMed ID: 6628530
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Simple and Sensitive Method for Auramine O Detection Based on the Binding Interaction with Bovin Serum Albumin.
    Yan J; Huang X; Liu S; Yang J; Yuan Y; Duan R; Zhang H; Hu X
    Anal Sci; 2016; 32(8):819-24. PubMed ID: 27506706
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A rapid spectrofluorimetric technique for determining drug-serum protein binding suitable for high-throughput screening.
    Parikh HH; McElwain K; Balasubramanian V; Leung W; Wong D; Morris ME; Ramanathan M
    Pharm Res; 2000 May; 17(5):632-7. PubMed ID: 10888318
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Methodologic factors influencing plasma binding of alpha-1-acid glycoprotein-bound and albumin-bound drugs.
    Morse DS; Abernethy DR; Greenblatt DJ
    Int J Clin Pharmacol Ther Toxicol; 1985 Oct; 23(10):535-9. PubMed ID: 3934087
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The binding of Ca2+ to actin monomer is monitored by the fluorescence of actin-bound auramine O.
    Tellam RL; Turner JA
    Biochem J; 1984 Nov; 224(1):269-76. PubMed ID: 6508763
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chromatographic studies of drug interactions with alpha
    Beeram S; Bi C; Zheng X; Hage DS
    J Chromatogr A; 2017 May; 1497():92-101. PubMed ID: 28366566
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thermal stability and ligand-binding properties of human plasma alpha 1-acid glycoprotein (orosomucoid) as determined with fluorescent probes.
    Busby TF; Ingham KC
    Biochim Biophys Acta; 1986 May; 871(1):61-71. PubMed ID: 2870738
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Binding of several phenothiazine neuroleptics to a common binding site of alpha 1-acid glycoprotein, orosomucoid.
    El-Gamal S; Wollert U; Müller WE
    J Pharm Sci; 1983 Feb; 72(2):202-5. PubMed ID: 6131996
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transport of propranolol and lidocaine through the rat blood-brain barrier. Primary role of globulin-bound drug.
    Pardridge WM; Sakiyama R; Fierer G
    J Clin Invest; 1983 Apr; 71(4):900-8. PubMed ID: 6833493
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A competitive enzyme-linked immunosorbent assay for alpha 1-acid glycoprotein in serum and urine samples.
    Phillips A; Rowell FJ
    Clin Chem; 1988 Aug; 34(8):1569-71. PubMed ID: 3135959
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.